Cardioprotective Effect of Desferrioxamine

Acta Haematologica

Volumn 95, Issue 1, 1996, Pages 63-65

  Bel, Alain ^a   Emmanuel, Martinod ^a   Menasché, Philippe ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Cardioplegia; Desferrioxamine; Free radicals; Iron chelation; Reperfusion injury

Indexed keywords

CHELATING AGENT; DEFEROXAMINE; FREE RADICAL; IRON; RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CHELATION THERAPY; CLINICAL TRIAL; CYTOTOXICITY; HEART PROTECTION; HEART SURGERY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON CHELATION; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CARDIOPULMONARY BYPASS; DEFEROXAMINE; FREE RADICALS; HUMANS; IRON CHELATING AGENTS; MYOCARDIAL REPERFUSION INJURY;

EID: 0030051138     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000203950     Document Type: Article

References (21)

1. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW: Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a ana-phylatoxins. N Engl J Med 1981;304:497-503.
2. Fantone JC, Ward PA: Role of oxygen-derived free radicals and metabolites in leukocyte-de-pendent inflammatory reactions. Am J Pathol 1982;107:397-418.
3. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD: Complement activation and the damaging effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983;86:845-857.
4. Cavarocchi NC, England MD, Schaff HV, Russo P, Orszulak TA, Schnell WA, O’Brien JF, Pluth JR: Oxygen free radical generation during cardiopulmonary bypass: Correlation with complement activation. Circulation 1986;74 (suppl 3): 130-133.
5. Zweier JL, Flaherty JT, Weisfeldt ML: Direct measurement of free radical generation following rcpcrfusion of ischemic myocardium. Proc Natl Acad Sci USA 1987;84:1404-1408.
6. Menasche P, Piwnica A: Free radicals and myocardial protection: A surgical viewpoint. Ann Thorac Surg 1989;47:939-945.
7. Gutteridge JMC, Richmond R, Halliwell B: Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine. Biochem J 1979;184:469-472.
8. Aust SD, Morehouse LA, Thomas CE: Role of metals in oxygen radical reactions. J Free Radic Biol Med 1985;1:3-25.
9. Biemond P, Swaak AJG, Beindort TCM, Koster JF: Superoxidc-dependent and -independent mechanism of iron mobilization from ferritine by xanthine oxidase. Biochem J 1986;239:169-173.
10. Mostert LJ, Van Dorst JALM, Koster JF, Van Eijk HG, Kontoghiorghes GJ: Free radical and cytotoxic effects of chelators and their iron complexes in the hepatocyte. Free Radic Res Commun 1987;3:379-388.
11. Sinaceur J, Ribière C, Nordmann J, Nordmann R: Desferrioxamine: A scavenger of superoxide radicals. Biochem Pharmacol 1984;33:1693— 1694.
12. Ambrosio G, Zweier JL, Jacobus WE, Weisfeldt ML, Flaherty JT: Improvement of post-ischemic myocardial function and metabolism induccd by administration of deferoxamine at the time of reflow: The role of iron in the pathogenesis of reperfusion injury. Circulation 1987; 76:906-915.
13. Milliner DS, Nebeker HG, Ott SM: Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy. Ann Intern Med 1984;101:775-780.
14. Simon P: Indications de la desferrioxamine chez les insuffisants rénaux chroniques traités par dialyse. Nephrologie 1986;7:177-180.
15. Badylak SF, Simmons A, Turek J, Babbs CF: Protection from reperfusion injury in the isolated rat heart by postischaemic deferoxamine and oxypurinol administration. Cardiovasc Res 1987;21:500-506.
16. Williams RE. Zweier JL. Flaherty JT: Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Circulation 1991; 83:1006-1014.
17. Bolli R, Patel BS, Zhu WX, O’Neill PG, Hartley CJ, Charlat ML, Roberts R: The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction. Am J Physiol 1987; 253:1372-1380.
18. Bernier M, Hearse DJ, Manning AS: Reperfu-sion-induced arrhythmias and oxygen derived free radical studies with ‘anti-free radical’ interventions and a free radical generating system in the isolated perfused rat heart. Circ Res 1986;58:331-340.
19. Ferreira R, Burgos M, Milei J, Llesuy S, Moltc-ni L, Hourqucbic H, Boveris A: Effect of supplemented cardioplegic solution with deferoxamine on reperfused human myocardium. J Thorac Cardiovasc Surg 1990;100:708-714.
20. Drossos G, Lazou A, Panagopoulos P, Westaby S: Deferoxamine cardioplegia reduces superoxide radical production in human myocardium. Ann Thorac Surg 1995;59:169-172.
21. Menaschd P, Pasquier C, Belluci S, Lorente P, Jaillon P, Piwnica A: Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man. J Thorac Cardiovasc Surg 1988;96:582-589.